233675-51-9

Basic information

• Product Name: [1,2,4]Triazolo[4,3-a]quinoxalin-1(2H)-one, 4,6-diamino-2-phenyl-
• CAS NO: 233675-51-9
• Molecular Formula: C15H12N6O
• Molecular Weight: 292.3
• Mol File: 233675-51-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [1,2,4]Triazolo[4,3-a]quinoxalin-1(2H)-one, 4,6-diamino-2-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: [1,2,4]Triazolo[4,3-a]quinoxalin-1(2H)-one, 4,6-diamino-2-phenyl-(233675-51-9)
• EPA Substance Registry System: [1,2,4]Triazolo[4,3-a]quinoxalin-1(2H)-one, 4,6-diamino-2-phenyl-(233675-51-9)

Safety Data

• Hazardous Substances Data: 233675-51-9(Hazardous Substances Data)

Upstream product

• 233675-50-8 4-amino-6-nitro-2-phenyl-2H-[1,2,4]triazolo[4,3-a]quinoxalin-1-one 
• 3694-52-8 2,3-diamino-nitrobenzene 
• 28663-68-5 ethyl chloro(2-phenylhydrazono)acetate 
• 233675-35-9 8-nitro-3-(phenyl-hydrazono)-3,4-dihydro-1H-quinoxalin-2-one 
• 856862-66-3 4-azido-6-nitro-2-phenyl-2H-[1,2,4]triazolo[4,3-a]quinoxalin-1-one 
• 28663-68-5 ethyl (phenylhydrazono)chloroacetate 
• 233675-35-9 3-phenylhydrazono-1,2,3,4-tetrahydro-8-nitroquinoxalin-2-one 
• 233675-38-2 1,2,4,5-tetrahydro-6-nitro-2-phenyl-1,2,4-triazolo<4,3-a>quinoxaline-1,4-dione 
• 636572-60-6 4-chloro-1,2-dihydro-6-nitro-2-phenyl-1,2,4-triazolo[4,3-a]quinoxalin-1-one 
• 62-53-3 aniline 
• 856862-67-4 C₃₃H₂₃N₆O₃P 
• 660438-82-4 4-amino-6-(4-methoxy-benzylamino)-2-phenyl-2H-[1,2,4]triazolo[4,3-a]quinoxalin-1-one 

Downstream Products

• 856862-89-0 N-(4-amino-1-oxo-2-phenyl-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinoxalin-6-yl)-2,2,2-trifluoroacetamide 
• 856862-68-5 4-amino-6-(benzylidene-amino)-2-phenyl-2H-[1,2,4]triazolo[4,3-a]quinoxalin-1-one 
• 660438-82-4 4-amino-6-(4-methoxy-benzylamino)-2-phenyl-2H-[1,2,4]triazolo[4,3-a]quinoxalin-1-one 

Relevant articles and documents

Derivatives of 4,6-diamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3-a] quinoxalin-2H-1-one: Potential antagonist ligands for imaging the A2A adenosine receptor by positron emission tomography (PET)

The importance of the brain A2A adenosine receptor (A 2AAR) in movement disorders urges the development of radiolabeled ligands for imaging those receptors by positron emission tomography (PET). This study evaluated one class of Asu

4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo[4,3- a]quinoxalin-1-one: A new A(2A) adenosine receptor antagonist with high selectivity versus A1 receptors

-